Cargando…

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension

BACKGROUND: Little attention has been paid to chest high resolution computed tomography (HRCT) findings in idiopathic pulmonary arterial hypertension (IPAH) patients so far, while a couple of small studies suggested that presence of centrilobular ground-glass opacifications (GGO) on lung scans could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kacprzak, Aneta, Burakowska, Barbara, Kurzyna, Marcin, Fijałkowska, Anna, Florczyk, Michał, Wieteska-Miłek, Maria, Darocha, Szymon, Torbicki, Adam, Szturmowicz, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597242/ https://www.ncbi.nlm.nih.gov/pubmed/34789251 http://dx.doi.org/10.1186/s12931-021-01893-8

Ejemplares similares

In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans
por: Szturmowicz, Monika, et al.
Publicado: (2010)

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters
por: Mańczak, Rafał, et al.
Publicado: (2020)

Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022)

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kurzyna, Marcin, et al.
Publicado: (2015)

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021)

An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery
por: Darocha, Szymon, et al.
Publicado: (2022)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement
por: Szturmowicz, Monika, et al.
Publicado: (2021)

Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020)

Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery
por: Kacprzak, Aneta, et al.
Publicado: (2023)

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy
por: Kacprzak, Aneta, et al.
Publicado: (2023)

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Organizing pneumonia: chest HRCT findings
por: Faria, Igor Murad, et al.
Publicado: (2015)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
por: Nowak, Marcin M., et al.
Publicado: (2022)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Significance of various pulmonary and extrapulmonary abnormalities on HRCT of the chest in scleroderma lung
por: Pandey, Anoop Kumar, et al.
Publicado: (2013)

Importance of chest HRCT in the diagnostic evaluation of fibrosing interstitial lung diseases
por: Torres, Pedro Paulo Teixeira e Silva, et al.
Publicado: (2021)

The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis
por: Refini, Rosa Metella, et al.
Publicado: (2020)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data
por: Fijałkowska, Anna, et al.
Publicado: (2017)

Performance of Radiomics Features in the Quantification of Idiopathic Pulmonary Fibrosis from HRCT
por: Stefano, Alessandro, et al.
Publicado: (2020)

Different chest HRCT scan protocols change the extent of ground glass opacities
por: Emilsson, Össur Ingi, et al.
Publicado: (2022)

Catheter-directed therapy to treat intermediate- and high-risk pulmonary embolism: Personal experience and review of the literature
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension
por: Tomaszewski, Michał, et al.
Publicado: (2022)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes
por: Torrisi, Sebastiano Emanuele, et al.
Publicado: (2018)

Occult pulmonary lymphangitic carcinomatosis presenting as 'chronic cough' with a normal HRCT chest
por: Jinnur, Praveen K., et al.
Publicado: (2016)

Association between Periodontitis and COVID-19 Based on Severity Scores of HRCT Chest Scans
por: Mishra, Supriya, et al.
Publicado: (2022)

The characteristics of chest HRCT and pulmonary function tests in lung‐onset primary sjogren's syndrome
por: Dong, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_27pb24mhhpl8odru8g04jssip7